Rockwell Medical

$0.9439
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0146 (-1.52%) Today
$0.00 (0.00%) As of 10:14 PM UTC after-hours

Why Robinhood?

You can buy or sell RMTI and other stocks, options, and ETFs commission-free!

About RMTI

Rockwell Medical, Inc. (DE) Common Stock, also called Rockwell Medical, is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI. The listed name for RMTI is Rockwell Medical, Inc. (DE) Common Stock.

CEO
Russell H. Ellison
Employees
299
Headquarters
Wixom, Michigan
Founded
1995
Market Cap
66.35M
Price-Earnings Ratio
Dividend Yield
Average Volume
948.58K
High Today
$0.9946
Low Today
$0.92
Open Price
$0.93
Volume
1.06M
52 Week High
$3.85
52 Week Low
$0.83

Collections

RMTI Earnings

-$0.18
-$0.15
-$0.12
-$0.09
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.10 per share
Actual
-$0.10 per share

You May Also Like